Updated Jul 16, 2026
Farrell Michael J. has filed 5 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $24.39M.

Michael J. Farrell is the Chief Executive Officer and Chairman of ResMed Inc., a leading global company in respiratory care devices. He has played a significant role in the company's growth and innovation in the treatment of sleep apnea and other respiratory conditions.
| Role | Chairman and CEO, Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | RMD | RESMED INC | S — Open-market sale | 5.0K | $218.55 | $1.09M |
| 2026-07-09 | RMD | RESMED INC | M — Option exercise | 5.0K | $146.34 | $730K |
| 2026-06-09 | RMD | RESMED INC | S — Open-market sale | 5.0K | $193.96 | $968K |
| 2026-06-09 | RMD | RESMED INC | M — Option exercise | 5.0K | $146.34 | $730K |
| 2026-05-11 | RMD | RESMED INC | S — Open-market sale | 5.0K | $207.82 | $1.04M |
| 2026-05-11 | RMD | RESMED INC | M — Option exercise | 5.0K | $146.34 | $730K |
| 2026-04-09 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 5.0K | $225.50 | $1.13M |
| 2026-04-09 | RMD | RESMED INC | M — Option exercise [10b5-1] | 5.0K | $146.34 | $730K |
| 2026-03-11 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 5.0K | $251.03 | $1.25M |
| 2026-03-11 | RMD | RESMED INC | M — Option exercise [10b5-1] | 5.0K | $146.34 | $730K |
| 2026-02-10 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 5.0K | $273.78 | $1.37M |
| 2026-02-10 | RMD | RESMED INC | M — Option exercise [10b5-1] | 5.0K | $146.34 | $730K |
| 2026-01-08 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 5.0K | $248.46 | $1.24M |
| 2026-01-08 | RMD | RESMED INC | M — Option exercise [10b5-1] | 5.0K | $146.34 | $730K |
| 2025-10-07 | RMD | RESMED INC | S — Open-market sale | 8.0K | $282.85 | $2.27M |
| 2025-10-07 | RMD | RESMED INC | M — Option exercise | 8.0K | $101.64 | $814K |
| 2025-09-08 | RMD | RESMED INC | S — Open-market sale | 8.0K | $278.14 | $2.23M |
| 2025-09-08 | RMD | RESMED INC | M — Option exercise | 8.0K | $101.64 | $814K |
| 2025-08-15 | RMD | RESMED INC | A — Grant or award | 12.3K | $0.00 | |
| 2025-08-07 | RMD | RESMED INC | S — Open-market sale | 8.0K | $279.48 | $2.24M |
Michael J. Farrell is the Chief Executive Officer and Chairman of ResMed Inc., a leading global company in respiratory care devices. He has played a significant role in the company's growth and innovation in the treatment of sleep apnea and other respiratory conditions.…
5 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 14 open-market sales ($24.39M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Farrell Michael J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.